Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-019056
Filing Date
2017-07-26
Accepted
2017-07-26 17:00:30
Documents
2
Period of Report
2017-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1666
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4146
  Complete submission text file 0000899243-17-019056.txt   7404
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALPINE IMMUNE SCIENCES, INC. 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address
PENG STANFORD L (Reporting) CIK: 0001711352 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 17983561